Health World Mauritania: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health World Mauritania.

Press releases published on June 1, 2026

11 hours ago

Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking

Indeterminate GlobeNewswire

11 hours ago

Lungpacer Medical Appoints Steven Pfanstiel as Chief Financial Officer

Indeterminate GlobeNewswire

11 hours ago

Verano Announces 1-for-5 Reverse Stock Split to Prepare the Company for Prospective U.S. Stock Exchange Listing

Indeterminate GlobeNewswire

11 hours ago

Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy

Indeterminate GlobeNewswire

11 hours ago

Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire

11 hours ago

Syndax to Host R&D Day Highlighting its Late-Stage Programs and Early-Stage Assets on July 14, 2026

Indeterminate GlobeNewswire

11 hours ago

Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 Demonstrating Potential Best-in-Class Profile and Every-12-Week Dosing in IgA Nephropathy

Indeterminate GlobeNewswire

11 hours ago

Monopar Presents Phase 2 ALXN1840 Data Demonstrating Liver Disease Stabilization and Neurologic Improvement in Treatment-Experienced Wilson Disease Patients at EASL 2026

Indeterminate GlobeNewswire

11 hours ago

Axsome Therapeutics Partners with the Headache Alliance to Highlight the Impact of Migraine During Migraine and Headache Awareness Month

Indeterminate GlobeNewswire

11 hours ago

Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory

Indeterminate GlobeNewswire

11 hours ago

Life Sciences Investment Opportunities Accelerate as AI and Genomics Drive $200+ Billion Market Expansion

Indeterminate GlobeNewswire

11 hours ago

Human Appeal Releases “Thrive with Dignity” Impact Report, Highlighting Support for Over 7.3 Million People Globally

Indeterminate GlobeNewswire

12 hours ago

Rejuvenate Biomed Completes Recruitment in Phase 2 Trial Assessing First-in-Class Multi-Pathway Therapeutic RJx-01 in COPD-Induced Sarcopenia

Indeterminate GlobeNewswire

12 hours ago

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study

Indeterminate GlobeNewswire

12 hours ago

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing

Indeterminate GlobeNewswire

12 hours ago

Aplagon Announces Review Publication on APAC, a First-in-Class Dual-Action Antithrombotic to Treat Unmet Clinical Needs in Thromboinflammatory Diseases

Indeterminate GlobeNewswire

13 hours ago

ITM Announces Phase 3 COMPETE Data Supporting Single-Timepoint Dosimetry for n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at SNMMI 2026

Indeterminate GlobeNewswire

13 hours ago

Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib

Indeterminate GlobeNewswire

16 hours ago

Intravacc and Primrose Bio Renew Partnership to Enhance Conjugate Vaccine Development

Indeterminate GlobeNewswire

16 hours ago

Curium Announces a Strategic Investment of Over €32 million in Saclay, France

Indeterminate GlobeNewswire